Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCavendish Plc Regulatory News (CAV)

Share Price Information for Cavendish Plc (CAV)

Share Price is delayed by 15 minutes
Get Live Data
9.25    0.00 (0.00%)
Bid:
9.00
Ask:
9.50
Spread: 0.50 (5.556%)
Market Cap: £31.06m
CAV Live PriceLast checked at - London Stock Exchange

Intraday Cavendish Plc Share Chart

Offer Update

2 Mar 2005 10:54

Chrysalis VCT PLC02 March 2005 Not for release, distribution or publication, in whole or in part, in or intothe United States, Canada, Australia or Japan 2 March 2005 Merger by way of recommended offers by Smith & Williamson Corporate Finance Limited on behalf of Chrysalis VCT plc ("Chrysalis") for each of Chrysalis A VCT plc ("Chrysalis A"), Chrysalis B VCT plc ("Chrysalis B") and Chrysalis C VCT plc ("Chrysalis C") (together the "Chrysalis Companies") Offers declared unconditional in all respects Chrysalis announces that, following Admission becoming effective earlier today,the Offers are unconditional in all respects. Consideration payable under the Offers will be paid (in the manner set out inthe Offer Document) by 16 March 2005 to those Chrysalis Companies Shareholdersin respect of whom valid acceptances have been received by today. Considerationin respect of valid acceptances of the Offers received after today will be paidto accepting Chrysalis Companies Shareholders within 14 days of such receipt. The Special Dividends described in the Offer Document will be paid on 16 March2005 to Chrysalis Companies Shareholders on the Chrysalis Companies' registersof members at the close of business on 1 March 2005 (the record date). As a result of the Offers being declared unconditional in all respects,applications will be made to the UKLA for the cancellation of the listing ofChrysalis Companies Shares on the Official List and to the London Stock Exchangefor the cancellation of trading of Chrysalis Companies Shares on its market forlisted securities. It is expected that such cancellations will take effect from28 April 2005. Enquiries: Smith & WilliamsonTel: 020 7637 5377Dr A BasirovDavid Jones Terms used in this announcement shall have the same meaning as those in theOffer Document and Listing Particulars. This announcement does not constitute an offer or an invitation to purchase orsubscribe for any securities. The Offers are being made solely by the OfferDocument and the Forms of Acceptance, which contain the full terms andconditions of the Offers, including details of how the Offers may be accepted. Smith & Williamson Corporate Finance Limited, which is authorised and regulatedin the United Kingdom by the Financial Services Authority, is acting exclusivelyfor Chrysalis VCT plc and no one else in connection with the Offers and will notbe responsible to anyone other than Chrysalis VCT plc for providing theprotections afforded to customers of Smith & Williamson Corporate FinanceLimited nor for providing advice in relation to the Offers or any other matterreferred to herein. The Offers are not being made, directly or indirectly, in or into the UnitedStates, Canada, Australia or Japan and the Offer Document and the Forms ofAcceptance are not being, and should not be, mailed or otherwise distributed orsent in or into the United States, Canada, Australia or Japan or any otherjurisdiction if, in the latter case, to do so would constitute a violation ofthe relevant laws in such jurisdiction. The New Chrysalis Shares have not been, and will not be, registered under theUnited States Securities Act of 1933 (as amended) or under any relevantsecurities laws of any state or jurisdiction of the United States, Canada,Australia or Japan and no regulatory clearances in respect of the New ChrysalisShares have been, or will be, applied for in any jurisdiction. Accordingly,unless an exemption under the United States Securities Act of 1933 (as amended)or other relevant securities laws is applicable, the New Chrysalis Shares willnot be, and may not be, offered, sold, resold, delivered or distributed,directly or indirectly, in or into the United States, Canada, Australia or Japanor to, or for the account or benefit of, any United States person or personresident in Canada, Australia or Japan. This information is provided by RNS The company news service from the London Stock Exchange
12
Date   Source Headline
10th Apr 20263:18 pmRNSDirectors Dealings
1st Apr 20267:00 amRNSFull Year Trading Update
26th Feb 20263:38 pmRNSHolding(s) in Company
3rd Feb 20262:30 pmRNSDirectors Dealings
18th Dec 20259:08 amRNSDirectors Dealings
15th Dec 20254:15 pmRNSDirector Dealing: Correction
11th Dec 20254:00 pmRNSDirector Dealing
2nd Dec 20257:00 amRNSBlock Admission Return and Total Voting Rights
21st Nov 20254:45 pmRNSHolding(s) in Company
30th Oct 20257:00 amRNS2026 Interim Results
16th Oct 202510:23 amRNSDirector Dealing
1st Oct 20257:00 amRNSHalf Year Trading Update: Profitable First Half
16th Sep 202511:00 amRNSResult of AGM
29th Aug 20257:00 amRNSTotal Voting Rights
18th Jul 202512:07 pmRNSPosting of Annual Report and Notice of AGM
8th Jul 20254:39 pmRNSHolding(s) in Company
3rd Jul 202511:13 amRNS-RInvestor Presentation via Investor Meet Company
26th Jun 20257:00 amRNS2025 Full Year Results
24th Jun 202510:32 amRNSResponse to press speculation
2nd Jun 20257:00 amRNSBlock Admission Return and Total Voting Rights
27th May 20259:02 amRNSHolding(s) in Company
1st May 20254:56 pmRNSTotal Voting Rights
1st May 20254:55 pmRNSDirectors Dealings
9th Apr 20254:02 pmRNSDirector Dealing
4th Apr 20257:00 amRNSFull Year Trading Update
4th Feb 202512:39 pmRNSCompany Name Change
31st Jan 202511:26 amRNSDirectors Dealings
31st Jan 202511:22 amRNSDirector Dealings
12th Dec 20242:56 pmRNSDirectors Dealings
2nd Dec 20247:00 amRNSBlock Admission Return and Total Voting Rights
13th Nov 20243:00 pmRNSDirectors Dealings
11th Nov 20247:00 amRNS2025 Interim Results
21st Oct 20242:37 pmRNSDirectors Dealings
7th Oct 20247:00 amRNSHalf Year Trading Update: Profitable First Half
24th Sep 20249:20 amRNSIntended Purchases of Shares by EBT
16th Sep 202412:42 pmRNSResult of AGM
16th Sep 20249:09 amRNSAGM Trading Statement
6th Sep 20247:00 amRNSRule 19.6(c) Confirmation
15th Aug 20243:00 pmRNSDirectors Dealings
1st Aug 20248:44 amRNSPosting of Annual Report and Notice of AGM
26th Jul 20247:00 amRNSTotal Voting Rights
18th Jul 20244:33 pmRNSDirector Dealings
15th Jul 20247:00 amRNS2024 Full Year Results
12th Jun 20242:41 pmRNSHolding(s) in Company
24th May 20247:00 amRNSDirectorate Change
22nd Apr 202410:00 amRNSDirectors Dealings
8th Apr 20247:01 amRNSHolding(s) in Company
8th Apr 20247:00 amRNSChange of Nominated Adviser
4th Apr 20247:00 amRNSTrading Update
28th Mar 20247:00 amRNSTotal Voting Rights
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.